Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16082
Title: Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study
Austin Authors: Garg, Mayur;Burrell, Louise M ;Velkoska, Elena;Griggs, Karen;Angus, Peter W ;Gibson, Peter R;Lubel, John S
Affiliation: Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
Department of Gastroenterology and Hepatology, Eastern Health, Box Hill, Victoria, Australia
Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
Department of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia
Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Sep-2015
metadata.dc.date: 2014-02-06
Publication information: Journal of the Renin-Angiotensin-Aldosterone System 2015; 16(3):559-569
Abstract: INTRODUCTION: The relationship between intestinal inflammation and circulating components of the renin-angiotensin system (RAS) is poorly understood. MATERIALS AND METHODS: Demographic and clinical data were obtained from healthy controls and patients with inflammatory bowel disease (IBD). Plasma concentrations of the classical RAS components (angiotensin-converting enzyme (ACE) and angiotensin II (Ang II)) and alternative RAS components (ACE2 and angiotensin (1-7) (Ang (1-7))) were analysed by radioimmuno- and enzymatic assays. Systemic inflammation was assessed using serum C-reactive protein (CRP), white cell count, platelet count and albumin, and intestinal inflammation by faecal calprotectin. RESULTS: Nineteen healthy controls (11 female; mean age 38 years, range 23-68), 19 patients with Crohn's disease (11 female; aged 45 years, range 23-76) and 15 patients with ulcerative colitis (6 female; aged 42 years, 26-64) were studied. Circulating classical RAS component levels were similar across the three groups, whereas ACE2 activity and Ang (1-7) concentrations were higher in patients with IBD compared to controls (ACE2: 21.5 vs 13.3 pmol/ml/min, p<0.05; Ang (1-7): 22.8 vs 14.1 pg/ml, p<0.001). Ang (1-7) correlated weakly with platelet and white cell counts, but not calprotectin or CRP, in patients with IBD. CONCLUSIONS: Circulating components of the alternative RAS are increased in patients with IBD.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16082
DOI: 10.1177/1470320314521086
ORCID: 0000-0003-1863-7539
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/24505094
Type: Journal Article
Subjects: Crohn’s disease
Renin-angiotensin system
Angiotensin (1–7)
Angiotensin II
Angiotensin-converting enzyme
Angiotensin-converting enzyme 2
Inflammatory bowel disease
Ulcerative colitis
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.